adenosine diphosphate has been researched along with Dysmyelopoietic Syndromes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, MT; Butta, NV; de Paz, R; Fernández Bello, I; García Arias Salgado, E; Jiménez-Yuste, V; Martín, M | 1 |
| Frederiksen, H; Hvas, AM; Nielsen, C; Sprogøe, U; Vinholt, PJ | 1 |
| Girtovitis, FI; Ioannidis, G; Makris, PE; Ntaios, G; Papadopoulos, A | 1 |
| Elias, L; Savage, B; Smith, KJ; Van Epps, DE | 1 |
| Blanco, A; de Tezanos Pinto, M; Dupont, J; Fernández, J; Lazzari, M; Maugeri, N; Meschengieser, S | 1 |
5 other study(ies) available for adenosine diphosphate and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Analysis of Variance; Annexin A5; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Blood Coagulation; Blood Platelets; Blotting, Western; Case-Control Studies; Caspases; Cell-Derived Microparticles; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Peptide Fragments; Platelet Activation; Platelet Count; Thrombelastography; Thrombin; Thrombocytopenia; Thrombopoietin; Young Adult | 2013 |
Measurement of platelet aggregation, independently of patient platelet count: a flow-cytometric approach.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Carrier Proteins; Female; Flow Cytometry; Hemorrhage; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; P-Selectin; Peptides; Platelet Aggregation; Platelet Count; Platelet Function Tests; Reference Values; Reproducibility of Results; Risk; Thrombocytopenia; Young Adult | 2017 |
Defective platelet aggregation in myelodysplastic syndromes.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Collagen; Epinephrine; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Platelet Aggregation; Ristocetin; Time Factors | 2007 |
A trial of recombinant alpha 2 interferon in the myelodysplastic syndrome: II. Characterization and response of granulocyte and platelet dysfunction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Platelets; Chemotaxis, Leukocyte; Granulocytes; Humans; Interferon Type I; Myelodysplastic Syndromes; Peroxidase; Platelet Aggregation; Prospective Studies; Receptors, Formyl Peptide; Receptors, Immunologic; Superoxides | 1987 |
Platelet function and intraplatelet von Willebrand factor antigen and fibrinogen in myelodysplastic syndromes.
Topics: Adenosine Diphosphate; Aged; Antigens; Bleeding Time; Blood Platelets; Cytoplasm; Epinephrine; Female; Fibrinogen; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Platelet Adhesiveness; Platelet Aggregation; Platelet Count; von Willebrand Factor | 1987 |